Predictors for severe cardiac complications after hematopoietic stem cell transplantation
Open Access
- 5 April 2004
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 33 (10) , 1043-1047
- https://doi.org/10.1038/sj.bmt.1704487
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescueBone Marrow Transplantation, 2003
- Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977–1997Bone Marrow Transplantation, 2001
- Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fractionBone Marrow Transplantation, 2001
- Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factorsBone Marrow Transplantation, 2000
- QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamideThe Lancet, 2000
- Predictive value of left ventricular ejection fraction in stem cell transplantationBone Marrow Transplantation, 1999
- Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.Journal of Clinical Oncology, 1995
- Early assessment of a new anticancer drug analogue — are the historical comparisons obsolete? The French experience with pirarubicinEuropean Journal Of Cancer, 1992
- Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.Journal of Clinical Oncology, 1991
- Antitumor activity in mice of 4′-Deoxydoxorubicin in comparison with doxorubicinEuropean Journal of Cancer and Clinical Oncology, 1983